Molecule 16673-34-0: a new tool in our arsenal against inflammation. 

<br/><br/>Available online from MWHC library: 1996 - present 
<br/><br/> The NLRP3 inflammasome has been shown to modulate IL-1B and IL-18 production, both key molecular regulators of inflammation. This editorial discusses a new molecule 16673-34-0 that inhibits the NLRP3 inflammasome and decreases caspase 1 production following ischemia reperfusion or acute peritonitis in mice. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Anti-Inflammatory Agents, Non-Steroidal/tu [Therapeutic Use]<br/>*Benzamides/tu [Therapeutic Use]<br/>*Carrier Proteins/ai [Antagonists & Inhibitors]<br/>*Inflammasomes/ai [Antagonists & Inhibitors]<br/>*Myocardial Reperfusion Injury/dt [Drug Therapy]<br/>*Sulfonamides/tu [Therapeutic Use]<br/>Animals<br/>Benzamides/cs [Chemical Synthesis]<br/>Blood Glucose/me [Metabolism]<br/>Cell Line<br/>Macrophages/de [Drug Effects]<br/>Male<br/>Mice<br/>Peritonitis/ci [Chemically Induced]<br/>Peritonitis/pc [Prevention & Control]<br/>Sulfonamides/cs [Chemical Synthesis]
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article